Telehealth support for chronic graft-versus-host disease
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial offers a group telehealth program for adults who have chronic graft-versus-host disease (cGVHD) after a stem cell transplant. The program aims to help manage symptoms and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a stem cell transplant from a donor
- You have moderate to severe chronic graft-versus-host disease (GVHD) as reported by you
- You can join group sessions in English or Spanish over video or phone
- You do not have a major untreated mental health or thinking problem that would prevent participation
- Your cancer is not actively growing back and needing treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three drugs (vedolizumab, cyclophosphamide, and tacrolimus) to prevent graft-versus-host disease, a common complication after a donor stem cell transplant. It is for people with certain blood cancers who are getting a reduced-intensity transplant.
This study tests a smartphone app to help patients and doctors manage care during a bone marrow transplant. If you are planning a transplant, the app may give you clear guidance and education.
This study looks at immune cells in your blood and in tissues affected by chronic graft-versus-host disease (a condition where donor cells attack your body) after a stem cell transplant. By analyzing samples, researchers hope to better understand this condition and improve future treatments.
This study tests whether a mindfulness program can help reduce symptoms and improve quality of life for people living with chronic graft-versus-host disease (cGVHD). You would attend group sessions (in person or virtual) to learn mindfulness techniques.
This trial tests a new way to prevent graft-versus-host disease (GvHD), a common complication after a stem cell transplant. It is for people with certain blood cancers who are getting a stem cell transplant from a half-matched family member or unrelated donor.
This study follows patients who have had a stem cell transplant and developed chronic graft-versus-host disease (a condition where transplanted cells attack the body). Researchers will track your symptoms and collect blood samples to understand what affects how well patients do over time.
Hear when a new Bone Marrow Transplant Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.